<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39340619</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-8221</ISSN><JournalIssue CitedMedium="Internet"><Volume>177</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Bulletin of experimental biology and medicine</Title><ISOAbbreviation>Bull Exp Biol Med</ISOAbbreviation></Journal><ArticleTitle>Relationship between HLA-II Gene Polymorphisms and Immune Response in COVID-19 Survivors and Volunteers Vaccinated against This Infection.</ArticleTitle><Pagination><StartPage>653</StartPage><EndPage>657</EndPage><MedlinePgn>653-657</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10517-024-06243-4</ELocationID><Abstract><AbstractText>The polymorphism of HLA class II genes was studied in COVID-19 survivors and vaccinated people. Six allelic variants of DQA1, 10 of DQB1, and 11 of DRB1 were identified. The DQA1*05:01 allele predominated in vaccinated volunteers and the DQA1*02:01, *01:03, and DQB1*06:02-8 alleles predominated in convalescents. In the groups with DQA1*01:01, *05:01 and *06:01 alleles, a high proportion of individuals seropositive for SARS-CoV-2 S protein was found. In the group with DQA1*02:01 allele, 40% of volunteers were found to have IgM and a significantly lower quantity of IgG to N protein of coronavirus. Comparative analysis showed a statistically significant increase in IL-10 levels in carriers of the DQA1*01:01 allele, which may indicate the influence of this allele on cytokine production. Further study of the immune response indices and their association with HLA class II gene polymorphism will provide better understanding of the mechanisms of COVID-19 immunogenesis.</AbstractText><CopyrightInformation>Â© 2024. Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dubrovina</LastName><ForeName>V I</ForeName><Initials>VI</Initials><AffiliationInfo><Affiliation>Irkutsk Antiplague Research Institute, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Irkutsk, Russia. dubrovina-valya@mail.ru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bryukhova</LastName><ForeName>D D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Irkutsk Antiplague Research Institute, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Irkutsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korytov</LastName><ForeName>K M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Irkutsk Antiplague Research Institute, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Irkutsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pyatidesyatnikova</LastName><ForeName>A B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Irkutsk Antiplague Research Institute, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Irkutsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vishnyakov</LastName><ForeName>V A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Irkutsk Antiplague Research Institute, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Irkutsk, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balakhonov</LastName><ForeName>S V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Irkutsk Antiplague Research Institute, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Irkutsk, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Bull Exp Biol Med</MedlineTA><NlmUniqueID>0372557</NlmUniqueID><ISSNLinking>0007-4888</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059866">HLA-DQ beta-Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C069051">HLA-DQB1 antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059848">HLA-DQ alpha-Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C069050">HLA-DQA1 antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="Y">Polymorphism, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059866" MajorTopicYN="Y">HLA-DQ beta-Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059811" MajorTopicYN="N">HLA-DRB1 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059848" MajorTopicYN="N">HLA-DQ alpha-Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">19; cytokine</Keyword><Keyword MajorTopicYN="N">2; COVID</Keyword><Keyword MajorTopicYN="N">CoV</Keyword><Keyword MajorTopicYN="N">II; SARS</Keyword><Keyword MajorTopicYN="N">immunity; HLA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>11</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39340619</ArticleId><ArticleId IdType="doi">10.1007/s10517-024-06243-4</ArticleId><ArticleId IdType="pii">10.1007/s10517-024-06243-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Troshina EA, Yukina MYu, Nuralieva NF, Mokrysheva NG. The role of HLA genes: from autoimmune diseases to COVID-19. Problem. Endokrin. 2020;66(4):9-15. Russian. https://doi.org/10.14341/probl12470</Citation></Reference><Reference><Citation>Medhasi S, Chantratita N. Human leukocyte antigen (HLA) system: genetics and association with bacterial and viral infections. J. Immunol. Res. 2022;2022:9710376. https://doi.org/10.1155/2022/9710376</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/9710376</ArticleId><ArticleId IdType="pubmed">35664353</ArticleId><ArticleId IdType="pmc">9162874</ArticleId></ArticleIdList></Reference><Reference><Citation>Choo SY. The HLA system: genetics, immunology, clinical testing, and clinical implications. Yonsei Med. J. 2007;48(1):11-23. https://doi.org/10.3349/ymj.2007.48.1.11</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2007.48.1.11</ArticleId><ArticleId IdType="pubmed">17326240</ArticleId><ArticleId IdType="pmc">2628004</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmunity: From Bench to Bedside [Internet]. Anaya JM, Shoenfeld Y, Rojas-Villarraga A, Levy RA, Cervera R, eds. Bogota (Colombia): El Rosario University Press; 2013 Jul 18. ID NBK459447</Citation></Reference><Reference><Citation>Al Naqbi H, Mawart A, Alshamsi J, Al Safar H, Tay GK. Major histocompatibility complex (MHC) associations with diseases in ethnic groups of the Arabian Peninsula. Immunogenetics. 2021;73(2):131-152. https://doi.org/10.1007/s00251-021-01204-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00251-021-01204-x</ArticleId><ArticleId IdType="pubmed">33528690</ArticleId><ArticleId IdType="pmc">7946680</ArticleId></ArticleIdList></Reference><Reference><Citation>Mironova LV, Bondaryuk AN, Sidorova EA, Bochalgin NO, Fedotova IS, Bukin YuS, Ponomareva AS, Andaev EI, Balakhonov SV. Population genomics of SARS-CoV-2 in the constituent entities of Siberian and far eastern federal districts. Probl. Osobo Opasn. Infekts. 2023;(1):111-119. Russian. https://doi.org/10.21055/0370-1069-2023-1-111-119</Citation></Reference><Reference><Citation>Krechetova LV, Inviyaeva EV, Sadykov VF, Vtorushina VV, Ivanets TYu, Silachev DN, Pyregov AV, Dolgushina NV, Sukhikh GT. Immune status of COVID-19 patients with different disease severity. Akush. Gin. 2021;(8):75-85. Russian. https://doi.org/10.18565/aig.2021.8.75-85</Citation></Reference><Reference><Citation>Correale P, Mutti L, Pentimalli F, Baglio G, Saladino RE, Sileri P, Giordano A. HLA-B*44 and C*01 prevalence correlates with Covid19 spreading across Italy. Int. J. Mol. Sci. 2020;21(15):5205. https://doi.org/10.3390/ijms21155205</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21155205</ArticleId><ArticleId IdType="pubmed">32717807</ArticleId><ArticleId IdType="pmc">7432860</ArticleId></ArticleIdList></Reference><Reference><Citation>Langton DJ, Bourke SC, Lie BA, Reiff G, Natu S, Darlay R, Burn J, Echevarria C. The influence of HLA genotype on the severity of COVID-19 infection. HLA. 2021;98(1):14-22. https://doi.org/10.1111/tan.14284</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tan.14284</ArticleId><ArticleId IdType="pubmed">33896121</ArticleId><ArticleId IdType="pmc">8251294</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomita Y, Ikeda T, Sato R, Sakagami T. Association between HLA gene polymorphisms and mortality of COVID-19: An in silico analysis. Immun. Inflamm. Dis. 2020;8(4):684-694. https://doi.org/10.1002/iid3.358</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.358</ArticleId><ArticleId IdType="pubmed">33047883</ArticleId><ArticleId IdType="pmc">7654404</ArticleId></ArticleIdList></Reference><Reference><Citation>Shkurnikov M, Nersisyan S, Jankevic T, Galatenko A, Gordeev I, Vechorko V, Tonevitsky A. Association of HLA class I genotypes with severity of Coronavirus disease-19. Front. Immunol. 2021;12:641900. https://doi.org/10.3389/fimmu.2021.641900</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.641900</ArticleId><ArticleId IdType="pubmed">33732261</ArticleId><ArticleId IdType="pmc">7959787</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus Vaccination Statistics. URL: https://gogov.ru/articles/covid-v-stats</Citation></Reference><Reference><Citation>Tatarnikova VV, Kiseleva NO, Dubrovina VI, Vishnyakov VA, Bryukhova DD, Pyatidesyatnikova AB, Korytov KM, Sharakshanov MB, Balakhonov SV. Immune profile of COVID-19 survivors and contacts during 9 months: a cohort study. Infect Dis Immun. 2023;3(4):163-175. https://doi.org/10.1097/ID9.0000000000000100</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ID9.0000000000000100</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryukhova DD, Dubrovina VI, Kiseleva NO, Pyatidesyatnikova AB, Korytov KM, Balakhonov SV. Assessment of indicators of specific humoral immune against COVID-19 in children during the distribution of a new coronavirus infection in the Irkutsk region (2020-2021). Acta Biomedica Scientifica. 2023;8(1):239-246. Russian. https://doi.org/10.29413/ABS.2023-8.1.24</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>